Statistics for Creo Medical Group plc (id:3907 CREO)
Valuation metrics
Market cap
62.32M
Enterprise value
58.20M
Trailing P/E (ttm)
-271.43
Forward P/E
5.00
PEG ratio
5.00
Price/Sales (ttm)
2.06
Price/Book (mrq)
112.60
Enterprise Value/Revenue
1.92
Enterprise Value/EBITDA
-2.56
Overview
Shares outstanding
412.15M
Float
325.96M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
361.94K
Average volume (90 days)
Price summary
52-Week low
12.00
52-Week high
50.00
52-Week change
-93.42%
Beta
3.00
50-Day moving average
19.17
200-Day moving average
29.61
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
-73.93%
Operating margin
-89.47%
Operational effectiveness
Return on assets
-20.10%
Return on equity
-38.49%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
15.30M
EBITDA
-22,700,000.00
Net income to common (ttm)
-22,400,000.00
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
9.80M
Total cash per share (mrq)
5.00
Total debt (mrq)
14.20M
Total Debt/Equity (mrq)
29.96
Current ratio (mrq)
324.20%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-20,100,000.00
Levered free cash flow (LFCF)
-14,950,000.00